Phase I clinical trial of WT1 peptide vaccine therapy for pediatric cancers
Phase 1
- Conditions
- Pediatric cancers
- Registration Number
- JPRN-UMIN000011030
- Lead Sponsor
- Shinshu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with severe organ dysfunction, infection under treatment, blood abonormalities or bleeding tendency. 2.Patients with leukemia or lymphoma are excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety (Ratios of adverse events)
- Secondary Outcome Measures
Name Time Method Overall survival, The ratio of the patients who completed the course, WT1 specific CTL rate in peripheral blood mononuclear cells (PBMCs), Lymphocyte subsets, WT1-specific interferon-gamma production of PBMCs